InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,633.91
(
1.02%
)
US TECH 100
20,107.60
(
-0.05%
)
Dow Jones
39,721.36
(
1.09%
)
Brent Oil
84.90
(
-0.18%
)
Bitcoin
58,162.48
(
0.70%
)
Post# of 23979
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

ash111

Send PM Follow Ignore
Followers 1054
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

ash111

Re: kei post# 7230

Wednesday, 05/13/2015 1:26:56 PM

Wednesday, May 13, 2015 1:26:56 PM

Post# of 23979
TPIV 1."promising data on both clinical programs in Breast and Ovarian Cancer".
2. "all our pre-clinical programs are seeing positive outcomes"
3. "giving us confidence in our ability to continue developing our products on the path to commercialization"
4. "Entry into Phase II HER2/neu Breast Cancer Trials"
5. "Entry into Phase II Triple Negative Cancer Trials and Fast Track & Orphan Drug Status"
6. "Produce new PolyStart ™ constructs, in-house, to facilitate collaborative efforts in our current clinical indications and those where others have already indicated interest in combination therapies."

10m market cap,32m O/S

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up